Daniel R. Vlock

CEO
clinical immunology
Cognoptix
United States of America

Biography

Dr. Vlock brings extensive pharmaceutical industry and academic experience in pharmaceutical drug development. Dr. Vlock is founder and CEO of Alopexx Pharmaceuticals which is developing a fully human monoclonal antibody directed against S. aureus

Research Interest

Clinical immunology

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America